From the September quarterly activities
• Lower unit cash operating costs1 of US$355/dmt.
So around $6.5m profit for the Dec quarter?
I reckon that’s not that bad but maths wasn’t my strongest subject. So correct me if I’m wrong.
Spodumene Prices, page-28
Add PLS (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.02 |
Change
0.080(2.72%) |
Mkt cap ! $9.090B | |||
| Open | High | Low | Value | Volume |
| $3.01 | $3.04 | $2.96 | $59.25M | 19.70M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 40915 | $3.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.02 | 318781 | 14 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| PLS (ASX) Chart |